Key result
Novel transcatheter mitral valve spacer balloon aims to directly reduce the regurgitant orifice in MR.
Why the study?
Transcatheter treatments for mitral valve regurgitation have generally been modeled on surgical procedures, but a novel approach to directly reduce the regurgitant orifice is needed.
Introduces a novel intravalvular spacer balloon as a transcatheter approach to treat mitral valve regurgitation.
Novel mitral spacer introduces direct orifice reduction option; leaves open safety, efficacy, and clinical role pending prospective trials.
Attempts at transcatheter treatment of mitral valve regurgitation have generally been modeled on proven surgical procedures such as leaflet repair, annuloplasty, or prosthetic valve implantation. We introduce a novel approach to directly reducing the regurgitant orifice: the mitral valve spacer, a balloon that attempts to reduce the regurgitant orifice.
No takes yet. Share an insight, caveat, or question.
Svensson et al. (2014) studied this question. The mitral valve spacer is introduced as a novel transcatheter balloon approach designed to directly reduce the regurgitant orifice in treating mitral valve regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: